In a groundbreaking move for the Indian biotech industry, IXP, a venture capital firm focused on life sciences, has launched its very first fund, the IXP Lifesciences Catalyst Fund. With an ambitious
Fibroheal Woundcare, an innovative startup that is pioneering the use of Silk proteins for wound care, has successfully raised Rs 6.3 crore in a pre-Series A funding round. This significant investment is
India IVF, one of the country’s pioneering tech-enabled fertility platforms, has successfully raised $1.25 million in its pre-Series A funding round. The funding, led by Tomorrow Capital, will help the startup expand
